National Health Commission: building a shelter hospital is by no means a signal of serious epidemic
At the press conference of the joint prevention and control mechanism of the State Council, Guo Yanhong, the supervisor of the medical administration and medical administration bureau of the National Health Commission, introduced that the construction of a shelter hospital is not a signal of a serious epidemic, but a quick response and preparedness according to the characteristics of the Omicron mutant.
This text is a result of machine translation.
Related companies：
In-depth
Apr 28, 2022 08:00 PM
Apr 26, 2022 12:26 PM
Apr 25, 2022 01:02 PM
Apr 21, 2022 07:07 PM
Insight
Financials
360 DigiTech: A Leader in an Oscillating Market
360 DigiTech's core competencies of asset-light model and technology focus offer a bright future. In the first quarter of 2022, the firm outperformed its competitors in terms of user amount, total loans granted and revenue. However, it operates in a market that has been performing below expectations as risks mount and profitability decreases.
Jun 25, 2022 10:00 AM
Briefing Dec 07, 2021 11:29 AM
· Real Estate
The real estate sector continued to rise, and many stocks such as sunshine city and Tieling new town rose by the limit
Briefing Nov 09, 2021 07:08 AM
· Real Estate
In October, the property market sales recovered month on month
In-depth
Healthcare
BeiGene: a Vast Opportunity Lies Ahead – But We Remain Cautious
BeiGene, a leader in China's novel pharmaceutical industry, recently received approval in Kuwait, Bahrain, and Qatar for its medication BRUKINSA (zanubrutinib). Previous contracts with major biopharma have produced substantial licensing income, but they did not lessen BeiGene's financial burden.
Jun 24, 2022 12:13 PM
See more
Read next
In-depth
Healthcare
Exclusive Interview with Xu Qian, Managing Partner of Redhill Capital
Updated 5 hours ago
In-depth
Technology
Successful Multinational Corporations in China Series: Qualcomm China
Jun 25, 2022 02:02 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.